
Building a Resilient Commercial Supply Chain for Antibody-Drug Conjugate Products: A Risk-Based Comparability Approach
Speaker Presentation: WCBP 2026
Jagani Dipkumar, Astellas Pharma US, Inc., 2026
Building a Resilient Commercial Supply Chain for Antibody-Drug Conjugate Products: A Risk-Based Comparability Approach